Evidence map›Paper›PMID 40100481›Full record

ArticleMikrochimica acta2025

Immunoelectrochemical assessment of human IgE in non-invasive samples of allergic individuals using PdNCs-labelled antibodies.

Alejandro Rodríguez-Penedo, Estefanía Costa-Rama, Rosario Pereiro, Beatriz Fernández, M Teresa Fernández-Abedul

Abstract read
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alejandro Rodríguez-PenedoDepartment of Physical and Analytical Chemistry, University of Oviedo, Julian Clavería 8, 33006, Oviedo, Spain.
Estefanía Costa-RamaDepartment of Physical and Analytical Chemistry, University of Oviedo, Julian Clavería 8, 33006, Oviedo, Spain.
Rosario PereiroDepartment of Physical and Analytical Chemistry, University of Oviedo, Julian Clavería 8, 33006, Oviedo, Spain.
Beatriz FernándezDepartment of Physical and Analytical Chemistry, University of Oviedo, Julian Clavería 8, 33006, Oviedo, Spain. fernandezbeatriz@uniovi.es.
M Teresa Fernández-AbedulDepartment of Physical and Analytical Chemistry, University of Oviedo, Julian Clavería 8, 33006, Oviedo, Spain. mtfernandeza@uniovi.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The escalating global prevalence of allergies presents a substantial public health challenge. Immunoglobulin E (IgE) serves as a key biomarker for allergic diseases, often measured in blood serum by ELISA immunoassays. Despite recent interest in minimally invasive sampling of biological fluids, the low sample volumes and IgE concentrations demand highly sensitive methodologies, typically confined to centralized laboratories. In this article, a decentralizable approach based on competitive immunoassays using Pd nanocluster (PdNCs)-labelled antibodies for electrochemical detection is proposed. With this aim, PdNCs were successfully bioconjugated with an anti-hIgE antibody to perform competitive immunoassays. To improve the analytical capabilities of the methodology, disposable screen-printed carbon electrodes with dual working electrodes were used for enhancing precision. Prior electrodeposition of PdNCs at - 0.6 V for 90 s significantly improved sensitivity (7.1 µA g ng⁻

Indexed as

Electrochemical TechniquesHypersensitivityImmunoglobulin EMetal NanoparticlesPalladiumElectrodesHumansImmunoassayLimit of DetectionImmunoglobulin EPalladiumAllergyElemental mass spectrometryIgE quantificationImmunoelectroanalysisLinear sweep voltammetryNon-invasive samplesPalladium nanoclusters

Identifiers

PMID40100481
PMCPMC11920355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.